162 related articles for article (PubMed ID: 36453343)
1. Clinical presentation and treatment outcomes of an algorithmic approach to uveal effusion syndrome.
Desai A; Parameswarappa DC; Senthil S; Jayanna S; Pappuru RR; Jalali S; Rani PK
Indian J Ophthalmol; 2022 Dec; 70(12):4349-4356. PubMed ID: 36453343
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report.
Onoe H; Shimada H; Kawamura A; Hirosawa H; Tanaka K; Mori R; Nakashizuka H
BMC Ophthalmol; 2022 Feb; 22(1):91. PubMed ID: 35197001
[TBL] [Abstract][Full Text] [Related]
3. Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report.
Kaewsangthong K; Thoongsuwan S; Uiprasertkul M; Phasukkijwatana N
BMC Ophthalmol; 2020 Jul; 20(1):311. PubMed ID: 32727414
[TBL] [Abstract][Full Text] [Related]
4. Rapid resolution of severe exudation in uveal effusion syndrome with anti-vascular endothelial growth factor alone in a case of bilateral nanophthalmos: a case report.
Song L; Dong F; Yi C
J Med Case Rep; 2021 Oct; 15(1):515. PubMed ID: 34663453
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Results of Vitrectomy and Sclerectomy in a Patient with Nanophthalmic Uveal Effusion Syndrome.
Popov I; Popova V; Krasnik V
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33572746
[TBL] [Abstract][Full Text] [Related]
6. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
[TBL] [Abstract][Full Text] [Related]
7. Uveal effusion syndrome mimicking severe chronic posterior uveitis: a case series of seven eyes of four patients.
Maggio E; Polito A; Prigione G; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):545-52. PubMed ID: 26376819
[TBL] [Abstract][Full Text] [Related]
8. Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.
Zhou N; Yang L; Xu X; Wei W
Front Med (Lausanne); 2022; 9():785444. PubMed ID: 35755052
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Nanophthalmos-Related Uveal Effusion with Two- vs. Four-Quadrant Partial-Thickness Sclerectomy and Sclerotomy Surgery.
Özdek Ş; Yalınbaş Yeter D; Özmen MC; Hasanreisoğlu M
Turk J Ophthalmol; 2022 Feb; 52(1):37-44. PubMed ID: 35196838
[TBL] [Abstract][Full Text] [Related]
10. Familial Nanophthalmos Presenting with Spontaneous Uveal Effusion Syndrome.
Bansal R; Menia NK; Gupta A
Ocul Immunol Inflamm; 2020; 28(2):191-193. PubMed ID: 30556758
[No Abstract] [Full Text] [Related]
11. CENTRAL SEROUS CHORIORETINOPATHY MIMICKING IDIOPATHIC UVEAL EFFUSION SYNDROME.
Boulanger E; Bonnin S; Delahaye-Mazza C; Tadayoni R; Gaudric A
Retin Cases Brief Rep; 2023 May; 17(3):288-293. PubMed ID: 34081041
[TBL] [Abstract][Full Text] [Related]
12. A modified ultrasound-guided surgical technique for the management of the uveal effusion syndrome in patients with normal axial length and scleral thickness.
Ghazi NG; Richards CP; Abazari A
Retina; 2013 Jun; 33(6):1211-9. PubMed ID: 23503341
[TBL] [Abstract][Full Text] [Related]
13. Multimodal imaging to aid in diagnosis of uveal effusion syndrome type 3.
Markan A; Moharana B; Dogra M; Singh R
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653850
[TBL] [Abstract][Full Text] [Related]
14. CLINICAL CHARACTERISTICS, TREATMENT MODALITIES, AND THEIR ASSOCIATION WITH LONG-TERM VISUAL OUTCOMES IN UVEAL EFFUSION SYNDROME.
Choi EY; Lee SM; Chun J; Choi YJ; Kim M
Retina; 2024 Apr; 44(4):642-651. PubMed ID: 38109673
[TBL] [Abstract][Full Text] [Related]
15. Persistent subretinal fluid after successful scleral buckle surgery for macula-off retinal detachment.
Wang XY; Shen LP; Hu RR; Xu W
Chin Med J (Engl); 2011 Dec; 124(23):4007-11. PubMed ID: 22340333
[TBL] [Abstract][Full Text] [Related]
16. UVEAL EFFUSION ASSOCIATED WITH LOCALIZED SCLERODERMA BECAUSE OF SCLERAL FIBROSIS.
Li S; Liu W; Zhao M; Li Y; Li X; Shi X
Retin Cases Brief Rep; 2023 Jul; 17(4):406-409. PubMed ID: 37364200
[TBL] [Abstract][Full Text] [Related]
17. Uveal Effusion Associated with Presumed Viral Encephalitis.
Lee DH; Kim TY; Lee SC; Kim M
Ocul Immunol Inflamm; 2022 Jan; 30(1):68-72. PubMed ID: 32816570
[TBL] [Abstract][Full Text] [Related]
18. Bilateral nanophthalmic uveal effusion syndrome: clinical presentation and surgical management.
Abell RG; Kerr NM; Vote BJ
Retin Cases Brief Rep; 2013; 7(4):386-90. PubMed ID: 25383821
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Case Series of Uveal Effusion Syndrome.
Claeys E; Stalmans P; Van Calster J; Casteels I; Stalmans I; Vandewalle E
J Glaucoma; 2020 Oct; 29(10):995-998. PubMed ID: 32769728
[TBL] [Abstract][Full Text] [Related]
20. Type III uveal effusion syndrome suspected to be related to pachychoroid spectrum disease: A case report.
Terubayashi Y; Morishita S; Kohmoto R; Mimura M; Fukumoto M; Sato T; Kobayashi T; Kida T; Ikeda T
Medicine (Baltimore); 2020 Jul; 99(31):e21441. PubMed ID: 32756157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
